A SOLID ORAL PHARMACEUTICAL FORMULATION COMPRISING ELTROMBOPAG OLAMINE

摘要

The present invention relates to a solid oral pharmaceutical formulation comprising the particle size d(0.9) of the eltrombopag olamine is less than 10 µm. The formulation eliminates problems of the active agent and provide additional advantages to the relevant prior art.